Supply Chain

Two-thirds of Californians do not support a drug price transparency bill before the California State Assembly, according to a recent survey commissioned by the Association for Accessible Medicines.

Tech-giant Samsung will widen its stake in the prescription drug market by producing novel drugs in partnership with Japan's Takeda Pharmaceutical Co., according to Reuters.

Patients across the globe are bracing themselves for the price of CTL019, a new leukemia drug deemed a "breakthrough" by physicians, according to Kaiser Health News.

Bella Pharmaceuticals on Friday issued a voluntary recall of its unexpired sterile drug products due to a lack of sterility assurance.

Financial incentives, social support and electronic reminders such as wireless pill bottles did not notably improve clinical outcomes or medication adherence among patients following heart attack, according to a study published in JAMA Internal Medicine.

Walmart followed Amazon's endeavor to establish a warehouse in the sky, which would deliver items to consumers via drones, according to CNBC.

In a recent press release, Ryder System, Inc. (NYSE: R), a leader in commercial fleet managementleet management, dedicated transportation, and supply chain solutions, announced its new partnership with TECSYS, an industry-leading supply chain management software company.

Medtronic on Tuesday reported an increase in first quarter revenue for the 2018 fiscal year, which ended July 28.

The following drug companies made headlines in the past two weeks.

Columbus, Ohio-based West-Ward Pharmaceuticals — the U.S. subsidiary of London-based Hikma Pharmaceuticals — increased the price of a common diarrhea drug by 430 percent, reports Financial Times.